ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, providing promising improvements across several medical and industrial programs. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, additional dependable substitute for therapeut